ARTERY THERAPEUTICS INC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.5Mattributed |
|---|---|
| Latest round | grant, $2.5M, 2025-01-01attributed |
| Founded | 2004 |
| Headquarters | SAN RAMON, California |
| Industry | bio |
| Stage | unknown |
| Website | arterytx.com |
Artery Therapeutics, Inc. (ARTERY) is a pre-clinical stage biotechnology company developing effective treatments for neurodegenerative and metabolic diseases. CURING APOE4 ASSOCIATED NEURODEGENERATIVE DISEASES, INCLUDING ALZHEIMER'S DISEASE BY TARGETING THE ABCA1 TRANSPORTER Artery Therapeutics, Inc. (Artery), a. Artery’s novel peptide library i.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $2.5M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Partytown, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.5M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.5M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | arterytx.com, read 2026-05-02 |
| Description | self-reported | arterytx.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.